RxDoctor Payments Data

James Zaccaria, DPM

Foot & Ankle Surgery · Bryn Mawr, PANPI 1194708149

Payments from drug & device makers

$5,679in general payments, 2019–2025

Across 167 payments — averaging $34.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Smith+Nephew$901
  • Organogenesis Inc.$628
  • Next Science LLC$553
  • Averitas Pharma Inc.$518
  • Kerecis Limited$495
  • plus $1K from 27 others
$1,741in research payments, 2019–2025

Across 5 payments — averaging $348.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Polarityte, Inc.$2K

What the payments were for

  • Consulting fees$531%
  • Food & beverage$5,62699%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,679 in reported general payments places this provider in the 70th percentile of 575 foot & ankle surgery providers in Pennsylvania.

See all foot & ankle surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$1,388,122
Medicare patients
619
Services billed
53,073

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl14$1,449
Ketoconazole34$868
Gabapentin99$766
Clobetasol Propionate13$619
Pregabalin21$590
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$355
Doxycycline Hyclate30$270
Cephalexin13$220
Methylprednisolone31$173
Nystatin11$128
Ciprofloxacin Hcl16$77
Tramadol Hcl23$67
Triamcinolone Acetonide11$52
Furosemide14$29

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Bryn Mawr

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →